Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMC Global Media Inc.AMCX · Entity 5454 | Director | June 12, 2019 | June 14, 2019 |
| AMGEN INCAMGN · Entity 2832 | Director | May 01, 2017 | May 04, 2017 |
| Madison Square Garden Sports Corp.MSG · Entity 3572 | Director | December 06, 2018 | December 10, 2018 |
| VIASAT INCVSAT · Entity 1744 | Director | September 04, 2019 | September 06, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMC Global Media Inc.
Report date June 12, 2019 · Filed June 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,566 |
Reported balance
After 2019-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-12 · Grant · Acquired 2,477 · Balance 4,566 F1: Each restricted stock unit is granted under the AMC Networks Inc. 2011 Amended and Restated Stock Plan for Non-Employee Directors and represents a right to receive one share of Class A Common Stock or the cash equivalent thereof. F3: Granted under the AMC Networks Inc. 2011 Amended and Restated Stock Plan for Non-Employee Directors for no consideration. F2: The restricted stock units are fully vested on the date of the grant and will be settled in cash or in stock on the first business day 90 days after service on the Board of Directors ceases. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit is granted under the AMC Networks Inc. 2011 Amended and Restated Stock Plan for Non-Employee Directors and represents a right to receive one share of Class A Common Stock or the cash equivalent thereof.
F2: The restricted stock units are fully vested on the date of the grant and will be settled in cash or in stock on the first business day 90 days after service on the Board of Directors ceases.
F3: Granted under the AMC Networks Inc. 2011 Amended and Restated Stock Plan for Non-Employee Directors for no consideration.
AMGEN INC
Report date May 01, 2017 · Filed May 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,635 |
Reported balance
After 2017-05-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-05-01 · Grant · Acquired 1,230 · Balance 36,635 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2: These shares include 1,712 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan (the Director Program) and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
F2: These shares include 1,712 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Madison Square Garden Sports Corp.
Report date December 06, 2018 · Filed December 10, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,564 |
Reported balance
After 2018-12-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-12-06 · Grant · Acquired 416 · Balance 1,564 F1: Each restricted stock unit is granted under The Madison Square Garden Company 2015 Stock Plan for Non-Employee Directors and represents a right to receive one share of Class A Common Stock or the cash equivalent thereof. F2: The restricted stock units are fully vested on the date of the grant and will be settled in stock or in cash on the first business day 90 days after service on the Board of Directors ceases. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit is granted under The Madison Square Garden Company 2015 Stock Plan for Non-Employee Directors and represents a right to receive one share of Class A Common Stock or the cash equivalent thereof.
F2: The restricted stock units are fully vested on the date of the grant and will be settled in stock or in cash on the first business day 90 days after service on the Board of Directors ceases.
VIASAT INC
Report date September 04, 2019 · Filed September 06, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| $.0001 par value common stockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2019-09-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-09-06 · Exercise / conversion · Acquired 1,600 · Balance 1,600 Row 2 · 2019-09-06 · Gift · Disposed 1,600 · Balance 0 F1: The restricted stock unit was granted to Frank Biondi, Jr. a director of Viasat, Inc. Upon vesting the shares were contributed to the Biondi Family Trust DTD 07/20/01. |
| $.0001 par value common stockSEC Table I · non-derivative | IndirectBy Trust | 9,400 |
Reported balance
After 2019-09-06 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2019-09-06 · Gift · Acquired 1,600 · Balance 9,400 |
| common stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.47 · Expires 2025-09-04 | Direct | 5,000 |
Reported balance
After 2019-09-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-09-04 · Grant · Acquired 5,000 · Balance 5,000 F2: The option vests on September 4, 2020. |
| restricted stock unitSEC Table II · derivative / convertible security | Direct | 1,600 |
Reported balance
After 2019-09-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-09-04 · Grant · Acquired 1,600 · Balance 1,600 F3: Each restricted stock unit represents a contingent right to receive one share of Viasat,Inc. common stock. F4: Subject to the reporting person's continued service as a Director of the Issuer, this award will vest and convert into shares of common stock of the Issuer on September 4, 2020. F5: Until vested, the restricted stock unit shall be subject to forfeiture in the event of termination of the directorship with the Issuer. |
| restricted stock unitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-09-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-09-06 · Exercise / conversion · Disposed 1,600 · Balance 0 F5: Until vested, the restricted stock unit shall be subject to forfeiture in the event of termination of the directorship with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit was granted to Frank Biondi, Jr. a director of Viasat, Inc. Upon vesting the shares were contributed to the Biondi Family Trust DTD 07/20/01.
F2: The option vests on September 4, 2020.
F3: Each restricted stock unit represents a contingent right to receive one share of Viasat,Inc. common stock.
F4: Subject to the reporting person's continued service as a Director of the Issuer, this award will vest and convert into shares of common stock of the Issuer on September 4, 2020.
F5: Until vested, the restricted stock unit shall be subject to forfeiture in the event of termination of the directorship with the Issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Seagate Technology Holdings plc
Report date October 27, 2017 · Filed October 27, 2017
Section 16 reporting ended · disclosed 2017-10-27. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2012 Filed Nov 29, 2012 23:50 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $74.89 | $0.00 |
DisclosureSEC source: 0001127602-12-032313 · form4.xml · derivative · entry 3 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2013-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2012 Filed Nov 29, 2012 23:50 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $88.10 | $440,512.00 |
DisclosureSEC source: 0001127602-12-032313 · form4.xml · nonDerivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,833 F1 · price: The price reported is an average price. The prices ranged from $88.10 to $88.12 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include 250 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 29, 2012 Filed Nov 29, 2012 23:50 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $74.89 | $374,450.00 |
DisclosureSEC source: 0001127602-12-032313 · form4.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-023269 · form4.xml · derivative · entry 5 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $50.78 | $0.00 |
DisclosureSEC source: 0001127602-12-023269 · form4.xml · derivative · entry 4 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2013-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:14 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 21,000 | $82.30 | $1,728,300.00 |
DisclosureSEC source: 0001127602-12-023269 · form4.xml · nonDerivative · entry 3 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,785 F1 · price: The price reported is an average price. The prices ranged from $82.27 to $82.33 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include 202 Dividend Equivalents ("DEs") granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $42.13 | $210,650.00 |
DisclosureSEC source: 0001127602-12-023269 · form4.xml · nonDerivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Jul 31, 2012 23:14 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,000 | $50.78 | $812,480.00 |
DisclosureSEC source: 0001127602-12-023269 · form4.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2012 Filed May 1, 2012 23:36 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $71.64 Strike: $71.64 | $358,200.00 |
DisclosureSEC source: 0001127602-12-015215 · form4.xml · derivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2022-04-27 Read SEC document |
| April 27, 2012 Filed May 1, 2012 23:36 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015215 · form4.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,728 F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 145 Dividend Equivalents ("DEs") granted pursuant to the Director Program. The acquisition of DEs had previously been reported in Table II of the director's Form 4 filings prior to the Company implementing a qualifying dividend reinvestment plan in 2012. DEs are credited on the director's unvested, and vested but deferred, RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 01, 2012 Filed Mar 1, 2012 23:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001127602-12-009023 · form4.xml · derivative · entry 3 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2012-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2012 Filed Mar 1, 2012 23:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $67.57 | $337,826.00 |
DisclosureSEC source: 0001127602-12-009023 · form4.xml · nonDerivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,188 F1 · price: The price reported is an average price. The prices ranged from $67.56 to $67.58 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| March 01, 2012 Filed Mar 1, 2012 23:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $58.61 | $293,050.00 |
DisclosureSEC source: 0001127602-12-009023 · form4.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2012 Filed Jan 12, 2012 21:36 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001127602-12-001634 · form4.xml · derivative · entry 5 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2012-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2012 Filed Jan 12, 2012 21:36 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 13,567 | $66.40 | $900,848.80 |
DisclosureSEC source: 0001127602-12-001634 · form4.xml · nonDerivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,188 Read SEC document |
| January 12, 2012 Filed Jan 12, 2012 21:36 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,000 | $56.30 | $900,800.00 |
DisclosureSEC source: 0001127602-12-001634 · form4.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $55.69 | $0.00 |
DisclosureSEC source: 0001127602-11-033100 · form4.xml · derivative · entry 5 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2012-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:39 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 52,921 | $63.14 | $3,341,431.94 |
DisclosureSEC source: 0001127602-11-033100 · form4.xml · nonDerivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,755 Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 60,000 | $55.69 | $3,341,400.00 |
DisclosureSEC source: 0001127602-11-033100 · form4.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2011 Filed Dec 12, 2011 23:49 UTC | AMGEN INC AMGN · Entity 2832 | GrantDividend Equivalent · Derivative | 45.736 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-031939 · form4.xml · derivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93.7881 Underlying: Common Stock · 45.736 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| September 08, 2011 Filed Sep 12, 2011 21:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantDividend Equivalent · Derivative | 48.0521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-025052 · form4.xml · derivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48.0521 Underlying: Common Stock · 48.0521 shares Expires not disclosed F1 · derivative.exercise_price: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.exercise_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. F1 · derivative.expiration_date: The Dividend Equivalents were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. The Dividend Equivalents are credited and deemed reinvested in the director's account in lieu of a cash dividend payment on the director's vested but deferred Restricted Stock Units. Dividend Equivalents will be paid in whole shares of the Company's common stock on a one-to-one basis on the director's elected deferral date, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 31, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 1,863.2 | $50.44 Strike: $50.44 | $93,979.81 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 16 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,863.2 shares Expires 2016-04-28 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| May 31, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 1,863.2 | $50.44 Strike: $50.44 | $93,979.81 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 15 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 26 Disclosed balance after: 0 Underlying: Common Stock · 1,863.2 shares Expires 2016-04-28 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 00:47 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $54.69 Strike: $54.69 | $273,450.00 |
DisclosureSEC source: 0001127602-11-013870 · form4.xml · derivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2021-04-25 Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 00:47 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013870 · form4.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,676 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| February 27, 2011 Filed Dec 22, 2011 21:39 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 8,138.73 | $55.69 Strike: $55.69 | $453,245.87 |
DisclosureSEC source: 0001127602-11-033100 · form4.xml · derivative · entry 4 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 8,138.73 shares Expires 2012-01-07 F1 · kind: On February 27, 2011, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of an assignment of the stock options held by the Annuity Trust in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Dec 22, 2011 21:39 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 8,138.73 | $55.69 Strike: $55.69 | $453,245.87 |
DisclosureSEC source: 0001127602-11-033100 · form4.xml · derivative · entry 3 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 19 Disclosed balance after: 0 Underlying: Common Stock · 8,138.73 shares Expires 2012-01-07 F1 · kind: On February 27, 2011, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of an assignment of the stock options held by the Annuity Trust in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Jan 12, 2012 21:36 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 2,137.2 | $56.30 Strike: $56.30 | $120,324.36 |
DisclosureSEC source: 0001127602-12-001634 · form4.xml · derivative · entry 4 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 2,137.2 shares Expires 2012-01-28 F1 · kind: On February 27, 2011, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of an assignment of the stock options held by the Annuity Trust in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Jan 12, 2012 21:36 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 2,137.2 | $56.30 Strike: $56.30 | $120,324.36 |
DisclosureSEC source: 0001127602-12-001634 · form4.xml · derivative · entry 3 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 20 Disclosed balance after: 0 Underlying: Common Stock · 2,137.2 shares Expires 2012-01-28 F1 · kind: On February 27, 2011, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of an assignment of the stock options held by the Annuity Trust in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 625.09 | $58.61 Strike: $58.61 | $36,636.52 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 12 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 625.09 shares Expires 2012-03-15 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 625.09 | $58.61 Strike: $58.61 | $36,636.52 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 11 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 24 Disclosed balance after: 0 Underlying: Common Stock · 625.09 shares Expires 2012-03-15 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 676.6 | $62.55 Strike: $62.55 | $42,321.33 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 10 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 676.6 shares Expires 2014-04-26 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 676.6 | $62.55 Strike: $62.55 | $42,321.33 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 9 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 23 Disclosed balance after: 0 Underlying: Common Stock · 676.6 shares Expires 2014-04-26 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 432.73 | $74.89 Strike: $74.89 | $32,407.15 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 8 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 432.73 shares Expires 2013-03-15 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 432.73 | $74.89 Strike: $74.89 | $32,407.15 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 7 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 22 Disclosed balance after: 0 Underlying: Common Stock · 432.73 shares Expires 2013-03-15 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 2,586.65 | $50.78 Strike: $50.78 | $131,350.09 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 6 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 2,586.65 shares Expires 2013-01-27 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 2,586.65 | $50.78 Strike: $50.78 | $131,350.09 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 5 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 21 Disclosed balance after: 0 Underlying: Common Stock · 2,586.65 shares Expires 2013-01-27 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 538.38 | $59.48 Strike: $59.48 | $32,022.84 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 4 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 538.38 shares Expires 2011-03-15 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| February 27, 2011 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 538.38 | $59.48 Strike: $59.48 | $32,022.84 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 3 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 18 Disclosed balance after: 0 Underlying: Common Stock · 538.38 shares Expires 2011-03-15 F2 · kind: In 2011, the Annuity Trust distributed the Annuity Payment to the Reporting Person in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| October 01, 2010 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 2,410.92 | $42.13 Strike: $42.13 | $101,572.06 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,410.92 shares Expires 2015-04-29 F1 · kind: In 2010, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| October 01, 2010 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 2,410.92 | $42.13 Strike: $42.13 | $101,572.06 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank Biondi, Jr. Annuity Trust No. 9 Disclosed balance after: 0 Underlying: Common Stock · 2,410.92 shares Expires 2015-04-29 F1 · kind: In 2010, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| May 31, 2010 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 3,136.8 | $50.44 Strike: $50.44 | $158,220.19 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 14 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,136.8 Underlying: Common Stock · 3,136.8 shares Expires 2016-04-28 F1 · kind: In 2010, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| May 31, 2010 Filed Feb 14, 2012 01:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftNqso (Right to Buy) · Derivative | 3,136.8 | $50.44 Strike: $50.44 | $158,220.19 |
DisclosureSEC source: 0001127602-12-005617 · form5.xml · derivative · entry 13 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank J. Biondi, Jr. Annuity Trust No. 26 Disclosed balance after: 1,863.2 Underlying: Common Stock · 3,136.8 shares Expires 2016-04-28 F1 · kind: In 2010, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| April 29, 2010 Filed Feb 2, 2011 22:22 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 2,589.08 | $42.13 Strike: $42.13 | $109,077.94 |
DisclosureSEC source: 0001127602-11-003549 · form5.xml · derivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,589.08 Underlying: Common Stock · 2,589.08 shares Expires 2015-04-29 F1 · kind: On April 29, 2010, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| April 29, 2010 Filed Feb 2, 2011 22:22 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 2,589.08 | $42.13 Strike: $42.13 | $109,077.94 |
DisclosureSEC source: 0001127602-11-003549 · form5.xml · derivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank Biondi, Jr. Annuity Trust No. 9 Disclosed balance after: 2,410.92 Underlying: Common Stock · 2,589.08 shares Expires 2015-04-29 F1 · kind: On April 29, 2010, the Annuity Trust, of which the Reporting Person is a trustee and a beneficiary, distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 22:37 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $58.43 Strike: $58.43 | $292,150.00 |
DisclosureSEC source: 0001127602-10-012362 · form4.xml · derivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-04-26 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 22:37 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012362 · form4.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,848 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 06, 2010 Filed Feb 2, 2011 22:20 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 1,718.55 | $58.61 Strike: $58.61 | $100,724.22 |
DisclosureSEC source: 0001127602-11-003542 · form5.xml · derivative · entry 28 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,374.91 Underlying: Common Stock · 1,718.55 shares Expires 2012-03-15 F2 · kind: On April 6, 2010, the Annuity Trust distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| April 06, 2010 Filed Feb 2, 2011 22:20 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 1,718.55 | $58.61 Strike: $58.61 | $100,724.22 |
DisclosureSEC source: 0001127602-11-003542 · form5.xml · derivative · entry 27 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Frank Biondi, Jr. Annuity Trust No. 7 Disclosed balance after: 0 Underlying: Common Stock · 1,718.55 shares Expires 2012-03-15 F2 · kind: On April 6, 2010, the Annuity Trust distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
| April 06, 2010 Filed Feb 2, 2011 22:20 UTC | AMGEN INC AMGN · Entity 2832 | OtherNqso (Right to Buy) · Derivative | 1,636.69 | $62.55 Strike: $62.55 | $102,374.96 |
DisclosureSEC source: 0001127602-11-003542 · form5.xml · derivative · entry 24 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,323.4 Underlying: Common Stock · 1,636.69 shares Expires 2014-04-26 F2 · kind: On April 6, 2010, the Annuity Trust distributed to the Reporting Person an annuity payment in the form of the assignment of a portion of the stock options held by the Annuity Trust (the "Annuity Payment") in satisfaction of the Annuity Trust's obligation to make annuity payments to the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.